abrdn Life Sciences Investors
HQL
44 hedge funds and large institutions have $46.3M invested in abrdn Life Sciences Investors in 2014 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 17 increasing their positions, 12 reducing their positions, and 7 closing their positions.
42% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 12
0% more funds holding
Funds holding: 44 → 44 (0)
0% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 7
3% less capital invested
Capital invested by funds: $47.7M → $46.3M (-$1.41M)
1.4% less ownership
Funds ownership: 15.87% → 14.47% (-1.4%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SIA
Sit Investment Associates
Minneapolis,
Minnesota
|
+$701K |
| 2 |
Wells Fargo
San Francisco,
California
|
+$436K |
| 3 |
LPL Financial
San Diego,
California
|
+$374K |
| 4 |
AIG
American International Group
New York
|
+$273K |
| 5 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$243K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Lazard Asset Management
New York
|
-$3.06M |
| 2 |
SFS
Shaker Financial Services
Arlington,
Virginia
|
-$1.07M |
| 3 |
BA
Bard Associates
Chicago,
Illinois
|
-$640K |
| 4 |
CFN
Cordasco Financial Network
Naples,
Florida
|
-$630K |
| 5 |
SG Americas Securities
New York
|
-$593K |
HQL Hedge Fund Activity: Q1 2014 in Review
44 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in abrdn Life Sciences Investors (HQL) for Q1 2014, worth a combined $46.3M — down 3% from $47.7M a quarter earlier.
Fund positioning in HQL was balanced in Q1 2014: 7 funds opened new positions, 7 closed out, 17 added to existing stakes and 12 trimmed.
The largest buyer was Sit Investment Associates, opening a new position worth an estimated $701K. The largest seller was Lazard Asset Management, exiting entirely with an estimated $3.06M sold.
- 44 institutional investors held abrdn Life Sciences Investors (HQL) as of Q1 2014, unchanged from Q4 2013.
- Funds reported $46.3M of abrdn Life Sciences Investors stock for Q1 2014, down 3% quarter-over-quarter.
- 7 funds opened new abrdn Life Sciences Investors positions in Q1 2014 and 7 closed out, a net change of 0 holders.
- The largest abrdn Life Sciences Investors buyer in Q1 2014 was Sit Investment Associates, an estimated $701K added.
- The largest abrdn Life Sciences Investors seller in Q1 2014 was Lazard Asset Management, an estimated $3.06M sold.
Based on aggregated 13F filings for Q1 2014.